SCHEDULE 13G

Maze Therapeutics Inc

Common Stock, par value $0.001 · CUSIP: 578784100

Event date: 2025-01-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Foresite Capital Fund IV, L.P.

  Shares: 2,111,917.00 · Class: 4.8%

• Foresite Capital Management IV, LLC

  Shares: 2,111,917.00 · Class: 4.8%

• Foresite Capital Fund V, L.P.

  Shares: 345,191.00 · Class: 0.8%

• Foresite Capital Management V, LLC

  Shares: 345,191.00 · Class: 0.8%

• James Tananbaum

  Shares: 2,457,108.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.